1 – 10 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A non-invasive 25-Gene PLNM-Score urine test for detection of prostate cancer pelvic lymph node metastasis
2024) In Prostate Cancer and Prostatic Diseases(
- Contribution to journal › Article
- 2021
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2020
-
Mark
Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
(
- Contribution to journal › Article
- 2017
-
Mark
Intermittent androgen deprivation therapy in patients with prostate cancer : Connecting the dots
(
- Contribution to journal › Article
- 2016
-
Mark
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
(
- Contribution to journal › Article
- 2015
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
- 2014
-
Mark
Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals Oncology Jan;25(1): 9-15, 2014).
(
- Contribution to journal › Letter
- 2013
-
Mark
Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
(
- Contribution to journal › Article